These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 25961262)

  • 1. CYP2D6 genotyping in breast cancer patients by liquid chromatography-electrospray ionization mass spectrometry.
    Beer B; Plattner S; Hubalek M; Oberguggenberger A; Sztankay M; Meraner V; Achleitner R; Oberacher H
    Horm Mol Biol Clin Investig; 2011 Oct; 6(3):247-53. PubMed ID: 25961262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6 genotyping by liquid chromatography-electrospray ionization mass spectrometry.
    Beer B; Erb R; Pitterl F; Niederstätter H; Maroñas O; Gesteira A; Carracedo A; Piatkov I; Oberacher H
    Anal Bioanal Chem; 2011 Jun; 400(8):2361-70. PubMed ID: 21225252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel amplification strategy for genotyping with liquid chromatography-electrospray ionization mass spectrometry.
    Beer B; Krjutškov K; Erb R; Viltrop T; Oberacher H
    Analyst; 2012 Nov; 137(22):5325-33. PubMed ID: 23034565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The next generation of DNA profiling--STR typing by multiplexed PCR--ion-pair RP LC-ESI time-of-flight MS.
    Pitterl F; Niederstätter H; Huber G; Zimmermann B; Oberacher H; Parson W
    Electrophoresis; 2008 Dec; 29(23):4739-50. PubMed ID: 19053072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous detection of single nucleotide polymorphisms and copy number variations in the CYP2D6 gene by multiplex polymerase chain reaction combined with capillary electrophoresis.
    Liao HW; Tsai IL; Chen GY; Kuo CT; Wei MF; Hwang TJ; Chen WJ; Shen LJ; Kuo CH
    Anal Chim Acta; 2013 Feb; 763():67-75. PubMed ID: 23340288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling 627 mitochondrial nucleotides via the analysis of a 23-plex polymerase chain reaction by liquid chromatography-electrospray ionization time-of-flight mass spectrometry.
    Oberacher H; Niederstätter H; Pitterl F; Parson W
    Anal Chem; 2006 Nov; 78(22):7816-27. PubMed ID: 17105176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.
    Ruddy KJ; Desantis SD; Gelman RS; Wu AH; Punglia RS; Mayer EL; Tolaney SM; Winer EP; Partridge AH; Burstein HJ
    Breast Cancer Res Treat; 2013 Oct; 141(3):421-7. PubMed ID: 24062210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres M; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(10 Suppl):S571-4. PubMed ID: 18957039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized suppression of adducts in polymerase chain reaction products for semi-quantitative SNP genotyping by liquid chromatography-mass spectrometry.
    Oberacher H; Parson W; Hölzl G; Oefner PJ; Huber CG
    J Am Soc Mass Spectrom; 2004 Dec; 15(12):1897-906. PubMed ID: 15589766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment.
    Park IH; Ro J; Park S; Lim HS; Lee KS; Kang HS; Jung SY; Lee S
    Breast Cancer Res Treat; 2012 Jan; 131(2):455-61. PubMed ID: 21437611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.
    Singh MS; Francis PA; Michael M
    Breast; 2011 Apr; 20(2):111-8. PubMed ID: 21185724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate determination of allelic frequencies in mitochondrial DNA mixtures by electrospray ionization time-of-flight mass spectrometry.
    Oberacher H; Niederstätter H; Huber CG; Parson W
    Anal Bioanal Chem; 2006 Mar; 384(5):1155-63. PubMed ID: 16421710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cytochrome P450 2D6 alleles using the Invader system.
    Nevilie M; Selzer R; Aizenstein B; Maguire M; Hogan K; Walton R; Welsh K; Neri B; de Arruda M
    Biotechniques; 2002 Jun; Suppl():34-8, 40-3. PubMed ID: 12083395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studies.
    Rodríguez-Antona C; Gurwitz D; de Leon J; Llerena A; Kirchheiner J; de Mesa EG; Ibarreta D
    Pharmacogenomics; 2009 Apr; 10(4):685-99. PubMed ID: 19374522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
    Schaeffeler E; Schwab M; Eichelbaum M; Zanger UM
    Hum Mutat; 2003 Dec; 22(6):476-85. PubMed ID: 14635107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography-electrospray ionization mass spectrometry for simultaneous detection of mtDNA length and nucleotide polymorphisms.
    Oberacher H; Niederstätter H; Parson W
    Int J Legal Med; 2007 Jan; 121(1):57-67. PubMed ID: 16955300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of DNA sequence variations in homo- and heterozygous samples via molecular mass measurements by electrospray ionization time-of-flight mass spectrometry.
    Oberacher H; Niederstätter H; Casetta B; Parson W
    Anal Chem; 2005 Aug; 77(15):4999-5008. PubMed ID: 16053315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy.
    Damodaran SE; Pradhan SC; Umamaheswaran G; Kadambari D; Reddy KS; Adithan C
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):75-81. PubMed ID: 22623212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis.
    Seruga B; Amir E
    Breast Cancer Res Treat; 2010 Aug; 122(3):609-17. PubMed ID: 20454926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.